PROTEOTECH, INC.

Company Information

Company Name
PROTEOTECH, INC.
Address
12040 115TH AVE N.E.
KIRKLAND, WA, 98034-
Phone
n/a
URL
n/a
DUNS
28808843
Number of Employees
n/a
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N

Award Totals

PROGRAM/PHASE
AWARD AMOUNT ($)
NUMBER OF AWARDS
SBIR Phase I
$2,646,792.00
11
SBIR Phase II
$7,164,885.00
5

Award List

  1. PROTEOGLYCAN SPLICING IN AD--THERAPEUTICS & DIAGNOSTICS

    Amount: $143,986.00

    Not Available Advances in sensor technology have significantly expanded the potential role of multi- and hyperspectral imaging in a wide range of military scenarios. However, for these advances to be ...

    SBIR Phase I 1999 Department of Health and Human Services
  2. N/A

    Amount: $197,006.00

    N/A

    SBIR Phase I 2000 Department of Health and Human Services
  3. N/A

    Amount: $272,398.00

    N/A

    SBIR Phase I 2000 Department of Health and Human Services
  4. N/A

    Amount: $249,401.00

    N/A

    SBIR Phase I 2000 Department of Health and Human Services
  5. AMYLOID INHIBITING AGENT FOR ALZHEIMERS DISEASE

    Amount: $227,501.00

    Not Available MCE will investigate the possibility of using multiple collectors and detectors to develop a DIMM that is both portable and capable of obtaining atmospheric turbulence data from stellar ...

    SBIR Phase I 1999 Department of Health and Human Services
  6. Amyloid Inhibiting Agent for Treatment of Alzheimer's

    Amount: $0.00

    Alzheimer's disease (AD) is a degenerative brain disorder characterized clinically by progressive loss of memory, cognition, reasoning, judgement and emotional stability that gradually leads to profou ...

    SBIR Phase I 2001 Department of Health and Human Services
  7. Amyloid Inhibiting Agent for Treatment of Alzheimer's

    Amount: $789,141.00

    Alzheimer's disease (AD) is a degenerative brain disorder characterized clinically by progressive loss of memory, cognition, reasoning, judgement and emotional stability that gradually leads to profou ...

    SBIR Phase II 2001 Department of Health and Human Services
  8. Alzheimer's Amyloid Plaque Persistence In Vivo

    Amount: $0.00

    DESCRIPTION (provided by applicant): Alzheimer's disease (AD) is a degenerative brain disorder characterized clinically by progressive loss of memory, cognition, reasoning, judgment ...

    SBIR Phase I 2001 Department of Health and Human Services
  9. Alzheimer's Amyloid Plaque Persistence In Vivo

    Amount: $485,177.00

    DESCRIPTION (provided by applicant): Alzheimer's disease (AD) is a degenerative brain disorder characterized clinically by progressive loss of memory, cognition, reasoning, judgment ...

    SBIR Phase II 2001 Department of Health and Human Services
  10. Laminin-Derived Protein Fragments as Inhibitors of Alzheimer's Amyloidosis

    Amount: $2,288,173.00

    DESCRIPTION (provided by applicant): Alzheimer's disease (AD) is a degenerative brain disorder characterized clinically by progressive loss of memory, cognition, reasoning, and judgment that gradually ...

    SBIR Phase II 2006 Department of Health and Human Services

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government